OBESITY AND CARDIOVASCULAR RISK
Clinical trials for OBESITY AND CARDIOVASCULAR RISK explained in plain language.
Never miss a new study
Get alerted when new OBESITY AND CARDIOVASCULAR RISK trials appear
Sign up with your email to follow new studies for OBESITY AND CARDIOVASCULAR RISK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to fight Obesity-Linked inflammation
Disease control Recruiting nowThis study tests an experimental drug called BGE-102 in 160 adults with obesity and heart risk factors. The goal is to see if it lowers inflammation (measured by hsCRP) safely. Participants take either BGE-102 or a placebo daily for 12 weeks.
Matched conditions: OBESITY AND CARDIOVASCULAR RISK
Phase: PHASE2 • Sponsor: BioAge Labs, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a common diabetes drug help obese nigerians lose weight?
Disease control Recruiting nowThis study tests whether metformin, a drug already used for diabetes, can help obese but non-diabetic Black Nigerians lose weight and lower their heart disease risk. Researchers will give 220 participants either metformin or a placebo for several months, tracking changes in weigh…
Matched conditions: OBESITY AND CARDIOVASCULAR RISK
Phase: PHASE3 • Sponsor: University Of Nigeria Teaching Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC